New Delhi: India all-rounder Yusuf Pathan was on Tuesday handed a five-month retrospective suspension for failing a dope test, a sanction which will end on January 14, after the BCCI accepted that the violation was inadvertent.
The 35-year-old Pathan had provided a urine sample as part of the BCCI’s anti-doping testing program during a domestic T20 competition on March 16 last year. “His sample was subsequently tested and found to contain Terbutaline. Terbutaline, a specified substance, is prohibited both In and Out of Competition in the WADA Prohibited List of Substances,” the BCCI stated.
The all-rounder, who has played 57 ODIs and 22 T20 Internationals for India, was charged with the “commission of an Anti-Doping Rule Violation (ADRV) under the BCCI Anti- Doping Rules (ADR) Article 2.1 and provisionally suspended pending determination of the charge”.
“Mr Pathan responded to the charge by admitting the ADRV and asserting that it was caused by his ingestion of a medication containing Terbutaline that had been mistakenly given to him instead of the medication prescribed for him, which did not contain any prohibited substance,” the BCCI explained.
The BCCI said it is “satisfied” with Pathan’s explanation that was using the medication to “treat an Upper Respiratory Tract Infection (URTI) and not as a performance-enhancing drug”.
Meanwhile, Pathan said he was confident of being cleared of deliberate usage and vowed to be more careful in future. "In hindsight, I should have been more careful and checked the status of the medications with BCCI's dedicated Anti-Doping Helpline," he said.